After successful preclinical evaluations, the drug progresses to clinical trials. These trials are conducted in phases to assess safety, efficacy, and optimal dosing in humans. Phase I focuses on evaluating safety and dosage, Phase II assesses efficacy and side effects, and Phase III confirms efficacy and monitors adverse reactions in larger populations.
